Used primarily in the development of pharmaceutical agents, this compound serves as a key intermediate in the synthesis of anti-inflammatory and antiproliferative drugs. Its structure supports binding to specific cellular targets involved in inflammation and cell growth regulation. It is investigated for potential use in treatments related to autoimmune disorders and certain cancers due to its ability to modulate enzyme activity and protein interactions. Additionally, it has been explored in research settings for designing urea-based inhibitors targeting kinases and other disease-relevant enzymes.